Fetuin-A Acts As an Endogenous Ligand of TLR4 to Promote Lipid-induced Insulin Resistance

Overview

Journal Nat Med

Specialties General Medicine
Molecular Biology

Date 2012 Jul 31

PMID 22842477

Citations 394

Authors

Durba Pal

Suman Dasgupta

Rakesh Kundu

Sudipta Maitra

Gobardhan Das

Satinath Mukhopadhyay

Sukanta Ray

Subeer S Majumdar

Samir Bhattacharya

Affiliations

Soon will be listed here.

Abstract

Toll-like receptor 4 (TLR4) has a key role in innate immunity by activating an inflammatory signaling pathway. Free fatty acids (FFAs) stimulate adipose tissue inflammation through the TLR4 pathway, resulting in insulin resistance. However, current evidence suggests that FFAs do not directly bind to TLR4, but an endogenous ligand for TLR4 remains to be identified. Here we show that fetuin-A (FetA) could be this endogenous ligand and that it has a crucial role in regulating insulin sensitivity via Tlr4 signaling in mice. FetA (officially known as Ahsg) knockdown in mice with insulin resistance caused by a high-fat diet (HFD) resulted in downregulation of Tlr4-mediated inflammatory signaling in adipose tissue, whereas selective administration of FetA induced inflammatory signaling and insulin resistance. FFA-induced proinflammatory cytokine expression in adipocytes occurred only in the presence of both FetA and Tlr4; removing either of them prevented FFA-induced insulin resistance. We further found that FetA, through its terminal galactoside moiety, directly binds the residues of Leu100-Gly123 and Thr493-Thr516 in Tlr4. FFAs did not produce insulin resistance in adipocytes with mutated Tlr4 or galactoside-cleaved FetA. Taken together, our results suggest that FetA fulfills the requirement of an endogenous ligand for TLR4 through which lipids induce insulin resistance. This may position FetA as a new therapeutic target for managing insulin resistance and type 2 diabetes.

Citing Articles

Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.

Li F, Li R, Deng H Front Pharmacol. 2025; 16:1521416.

PMID: 39925846 PMC: 11802817. DOI: 10.3389/fphar.2025.1521416.

Hepatokines and their role in cardiohepatic interactions in heart failure.

Shouman W, Najmeddine S, Sinno L, Dib Nehme R, Ghawi A, Ziade J Eur J Pharmacol. 2025; 992:177356.

PMID: 39922419 PMC: 11862882. DOI: 10.1016/j.ejphar.2025.177356.

Type 2 diabetes originated from non-alcoholic fatty liver disease.

Xiong X, Li X Life Metab. 2025; 2(1):load007.

PMID: 39872510 PMC: 11749538. DOI: 10.1093/lifemeta/load007.

NF-κB signaling is the major inflammatory pathway for inducing insulin resistance.

Mobeen A, Joshi S, Fatima F, Bhargav A, Arif Y, Faruq M 3 Biotech. 2025; 15(2):47.

PMID: 39845928 PMC: 11747027. DOI: 10.1007/s13205-024-04202-4.

The Role of Fetuin-A in Tumor Cell Growth, Prognosis, and Dissemination.

Odiase P, Ma J, Ranganathan S, Ogunkua O, Turner W, Marshall D Int J Mol Sci. 2024; 25(23).

PMID: 39684629 PMC: 11641224. DOI: 10.3390/ijms252312918.

References

Davis J, Gabler N, Walker-Daniels J, Spurlock M . Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring). 2008; 16(6):1248-55. DOI: 10.1038/oby.2008.210. View

Jiao P, Chen Q, Shah S, Du J, Tao B, Tzameli I . Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes. 2008; 58(1):104-15. PMC: 2606857. DOI: 10.2337/db07-1344. View

Tsukumo D, Carvalho-Filho M, Carvalheira J, Prada P, Hirabara S, Schenka A . Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 2007; 56(8):1986-98. DOI: 10.2337/db06-1595. View

Park B, Song D, Kim H, Choi B, Lee H, Lee J . The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009; 458(7242):1191-5. DOI: 10.1038/nature07830. View

Shi H, Kokoeva M, Inouye K, Tzameli I, Yin H, Flier J . TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006; 116(11):3015-25. PMC: 1616196. DOI: 10.1172/JCI28898. View

Fessler M, Rudel L, Brown J . Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol. 2009; 20(5):379-85. PMC: 3099529. DOI: 10.1097/MOL.0b013e32832fa5c4. View

Schwartz E, Zhang W, Karnik S, Borwege S, Anand V, Laine P . Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler Thromb Vasc Biol. 2010; 30(4):802-8. DOI: 10.1161/ATVBAHA.109.201681. View

Mathews S, Singh G, Ranalletta M, Cintron V, Qiang X, Goustin A . Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 2002; 51(8):2450-8. DOI: 10.2337/diabetes.51.8.2450. View

Orr J, Puglisi M, Ellacott K, Lumeng C, Wasserman D, Hasty A . Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes. 2012; 61(11):2718-27. PMC: 3478520. DOI: 10.2337/db11-1595. View

10.

Kim F, Pham M, Luttrell I, Bannerman D, Tupper J, Thaler J . Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res. 2007; 100(11):1589-96. DOI: 10.1161/CIRCRESAHA.106.142851. View

11.

Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama H . Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care. 2006; 29(2):468. DOI: 10.2337/diacare.29.02.06.dc05-1484. View

12.

Lassenius M, Pietilainen K, Kaartinen K, Pussinen P, Syrjanen J, Forsblom C . Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care. 2011; 34(8):1809-15. PMC: 3142060. DOI: 10.2337/dc10-2197. View

13.

Qatanani M, Lazar M . Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007; 21(12):1443-55. DOI: 10.1101/gad.1550907. View

14.

Ix J, Sharma K . Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol. 2010; 21(3):406-12. PMC: 4473254. DOI: 10.1681/ASN.2009080820. View

15.

Barton G, Medzhitov R . Toll-like receptor signaling pathways. Science. 2003; 300(5625):1524-5. DOI: 10.1126/science.1085536. View

16.

Kim J . Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab. 2006; 4(6):417-9. DOI: 10.1016/j.cmet.2006.11.008. View

17.

Mellgren R, Huang X . Fetuin A stabilizes m-calpain and facilitates plasma membrane repair. J Biol Chem. 2007; 282(49):35868-77. DOI: 10.1074/jbc.M706929200. View

18.

Stefan N, Fritsche A, Weikert C, Boeing H, Joost H, Haring H . Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008; 57(10):2762-7. PMC: 2551687. DOI: 10.2337/db08-0538. View

19.

Xu H, Barnes G, Yang Q, Tan G, Yang D, Chou C . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112(12):1821-30. PMC: 296998. DOI: 10.1172/JCI19451. View

20.

Dasgupta S, Bhattacharya S, Biswas A, Majumdar S, Mukhopadhyay S, Ray S . NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem J. 2010; 429(3):451-62. DOI: 10.1042/BJ20100330. View